We are live on ! Find out more
ICRM

Insight Capital Research & Management Portfolio holdings

AUM $177M
1-Year Est. Return 72%
This Fund
S&P 500
This Quarter Est. Return
+19.35%
1 Year Est. Return
+72%
3 Year Est. Return
+286.87%
5 Year Est. Return
10 Year Est. Return
AUM
$446M
AUM Growth
+$33M
Cap. Flow
-$5.17M
Cap. Flow %
-1.16%
Top 10 Hldgs %
21.59%
Holding
192
New
24
Increased
40
Reduced
70
Closed
53

Sector Composition

Rank Sector Weight
1 Industrials 22.79%
2 Technology 20.66%
3 Healthcare 12.55%
4 Consumer Discretionary 11.78%
5 Financials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRZO
51
DELISTED
Carrizo Oil & Gas Inc
CRZO
$3.65M 0.82%
81,458
-220,791
-73% -$9.39M
ULTI
52
DELISTED
Ultimate Software Group Inc
ULTI
$3.62M 0.81%
+23,619
New +$3.57M
TEN
53
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$3.41M 0.76%
60,300
-467
-0.8% -$25.4K
CSGP icon
54
CoStar Group
CSGP
$12.3B
$3.28M 0.73%
177,550
-6,210
-3% -$110K
ANAC
55
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$3.26M 0.73%
+194,493
New +$2.69M
CTSH icon
56
Cognizant
CTSH
$26B
$3.25M 0.73%
+64,396
New +$2.93M
WYNN icon
57
Wynn Resorts
WYNN
$10.6B
$3.19M 0.71%
16,412
+5,612
+52% +$957K
DGI
58
DELISTED
DigitalGlobe Inc.
DGI
$3.13M 0.7%
76,161
-720
-0.9% -$25.9K
QCOM icon
59
Qualcomm
QCOM
$176B
$3.08M 0.69%
41,439
+6,009
+17% +$424K
CPRI icon
60
Capri Holdings
CPRI
$1.74B
$2.96M 0.66%
36,405
+1,199
+3% +$94.6K
ACAD icon
61
Acadia Pharmaceuticals
ACAD
$5.03B
$2.87M 0.64%
114,775
-14,882
-11% -$351K
SFUN
62
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$2.86M 0.64%
+3,474
New +$2.18M
AMGN icon
63
Amgen
AMGN
$222B
$2.79M 0.62%
24,425
-35
-0.1% -$3.98K
AMZN icon
64
Amazon
AMZN
$2.96T
$2.79M 0.62%
139,720
-3,560
-2% -$64K
HD icon
65
Home Depot
HD
$355B
$2.74M 0.61%
33,302
+4,088
+14% +$319K
ALGN icon
66
Align Technology
ALGN
$12.3B
$2.65M 0.59%
+46,437
New +$2.5M
SINA
67
DELISTED
Sina Corp
SINA
$2.63M 0.59%
31,256
+19,665
+170% +$1.61M
PKG icon
68
Packaging Corp of America
PKG
$22.8B
$2.63M 0.59%
41,599
-10,974
-21% -$667K
IBM icon
69
IBM
IBM
$224B
$2.6M 0.58%
14,504
-1,018
-7% -$176K
NUS icon
70
Nu Skin
NUS
$267M
$2.59M 0.58%
18,728
+1,976
+12% +$233K
AGN
71
DELISTED
Allergan plc
AGN
$2.46M 0.55%
14,668
-89
-0.6% -$13.9K
JNJ icon
72
Johnson & Johnson
JNJ
$625B
$2.38M 0.53%
25,945
-1,551
-6% -$143K
INTU icon
73
Intuit
INTU
$89B
$2.37M 0.53%
+31,088
New +$2.23M
NM
74
DELISTED
Navios Maritime Holdings Inc.
NM
$2.36M 0.53%
21,123
+8,210
+64% +$663K
JCI icon
75
Johnson Controls International
JCI
$92.2B
$2.34M 0.52%
43,579
-108
-0.2% -$5.32K

Similar funds

Insight Capital Research & Management's Q4 2013 Portfolio in Review

As of Q4 2013, Insight Capital Research & Management held 192 positions worth $446M, up 8% from $413M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Insight Capital Research & Management's Q4 2013 filing shows 24 new, 40 increased, 70 reduced and 53 closed positions. Its largest new stake was Skechers: 643,683 shares worth $7.11M. The largest sale was Carrizo Oil & Gas Inc, an estimated $9.39M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Insight Capital Research & Management's largest Q4 2013 buy was Skechers: 643,683 shares worth $7.11M.
  • Insight Capital Research & Management added most to Medidata Solutions, Inc. in Q4 2013, an estimated $8.04M increase.
  • Insight Capital Research & Management's biggest Q4 2013 reduction was Carrizo Oil & Gas Inc, cutting an estimated $9.39M.
  • Insight Capital Research & Management fully exited Dauch Corp in Q4 2013, selling an estimated $7.7M.
  • Insight Capital Research & Management's ten largest holdings make up 22% of its $446M portfolio in Q4 2013.
  • Insight Capital Research & Management opened 24 new positions and closed 53 in Q4 2013.
  • Insight Capital Research & Management's portfolio value rose 8% quarter-over-quarter to $446M.

Based on Insight Capital Research & Management's 13F filing for Q4 2013, filed 12 Feb 2014.